GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (HKSE:01066) » Definitions » Cyclically Adjusted PB Ratio

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Cyclically Adjusted PB Ratio : (As of Apr. 30, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Shandong Weigao Group Medical Polymer Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co Cyclically Adjusted PB Ratio Chart

Shandong Weigao Group Medical Polymer Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.05 5.11 2.61 3.19 -

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.61 - 3.19 - -

Competitive Comparison of Shandong Weigao Group Medical Polymer Co's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Weigao Group Medical Polymer Co's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's Cyclically Adjusted PB Ratio falls into.



Shandong Weigao Group Medical Polymer Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Shandong Weigao Group Medical Polymer Co's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Shandong Weigao Group Medical Polymer Co's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book=Book Value per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=5.434/114.6694*114.6694
=5.434

Current CPI (Dec23) = 114.6694.

Shandong Weigao Group Medical Polymer Co Annual Data

Book Value per Share CPI Adj_Book
201412 2.756 99.000 3.192
201512 2.832 100.600 3.228
201612 2.942 102.600 3.288
201712 3.494 104.500 3.834
201812 3.646 106.500 3.926
201912 3.981 111.200 4.105
202012 4.727 111.500 4.861
202112 5.255 113.108 5.328
202212 5.318 115.116 5.297
202312 5.434 114.669 5.434

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shandong Weigao Group Medical Polymer Co  (HKSE:01066) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Shandong Weigao Group Medical Polymer Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Weigao Group Medical Polymer Co (HKSE:01066) Business Description

Traded in Other Exchanges
Address
No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Headlines

No Headlines